Along with other companions at the Nationwide Institutes of Health, NIDA is supporting investigation into psilocybin as a possible clinical treatment method for compound use disorders along with other mental ailments. 1P-LSD also called 1-Propionyl-Lyserguc Acid Diethylamide is a copyright compou